May 13
|
Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
|
May 13
|
Johnson & Johnson to sell remaining stake in Kenvue
|
May 13
|
Sector Update: Consumer Stocks Gain Premarket Monday
|
May 13
|
2 Supercharged Dividend Stocks to Buy and Hold for Years
|
May 13
|
We Think Johnson & Johnson (NYSE:JNJ) Can Stay On Top Of Its Debt
|
May 13
|
J&J to exit spinoff Kenvue with latest stake sale
|
May 13
|
J&J’s Megadyne discontinues pediatric electrode pad after burn reports
|
May 12
|
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
|
May 12
|
1 Passive Income Vehicle Every Investor Should Own
|
May 10
|
Prediction: 3 Sensational Stocks That'll Be Worth Far More Than Tesla 2 Years From Now
|
May 9
|
Johnson & Johnson (NYSE:JNJ) Is Increasing Its Dividend To $1.24
|
May 9
|
3 Reliable Dividend Stocks For Long-Term Passive Income
|
May 9
|
What Is the Dividend Payout for Johnson & Johnson Stock?
|
May 8
|
10 Future Dividend Kings in the Next 5 Years or Less
|
May 8
|
Analysts' 3 Favorite Dividend Aristocrats, Based On Latest Price Targets
|
May 8
|
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
|
May 8
|
Neutrogena Lost Dermatologists and Missed Out on the $42 Billion Beauty Boom
|
May 8
|
The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
|
May 7
|
15 Best S&P 500 Dividend Stocks To Buy Now
|
May 7
|
Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix
|